BackSpectrum Pharmaceuticals Overview

Spectrum Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SPPI.

Quarterly EBIT

-$4.87M
↑ 65.37% YoY

As of Mar 31, 2023

Annual EBIT (TTM)

-$63.50M
↑ 50.42% YoY

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin